NCT06238128

Brief Summary

The pervasive impact of the opioid epidemic has touched all layers of society for the past two decades, resulting in over 115 deaths daily and imposing annual costs of $78.5 billion. Responding swiftly to overdoses, akin to various medical emergencies, poses a significant challenge, particularly in geographically dispersed rural areas and densely populated urban settings. Effectively delivering the life-saving drug naloxone, which counteracts the effects of overdoses, necessitates a well-coordinated and cost-efficient response system. Simply opting for widespread distribution of naloxone, even with citizen involvement, proves to be a financially burdensome approach when compared to more targeted strategies. Moreover, obstacles such as limited access, inadequate or unavailable naloxone training, and delayed response times from emergency responders compound the problem. Addressing these issues, the proposed Opioid Rapid Response System (ORRS) project seeks to advance prevention science by adopting an innovative approach that incorporates technology and contemporary communication theory. The primary objective of the ORRS project is to mitigate opioid overdose deaths by enlisting and training citizens to administer naloxone in response to such events. Leveraging the PulsePoint health app, which connects citizens to cardiac events, the ORRS project will extend its capabilities to respond to overdose incidents. This initiative involves comprehensive development of ORRS, followed by a randomized clinical trial on a national scale to assess its effectiveness. The study aims to contribute to both prevention and implementation science by identifying optimal recruitment strategies and testing a model of online training. In pursuit of these objectives, the study is guided by the following Specific Aims: SA 1: Refine and complete the development of ORRS. SA 2: Conduct a randomized clinical trial to evaluate the effectiveness of the intervention. SA 3: Prepare ORRS for dissemination.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
773

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2023

Completed
6 months until next milestone

First Posted

Study publicly available on registry

February 2, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

May 24, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2025

Completed
Last Updated

January 23, 2026

Status Verified

January 1, 2026

Enrollment Period

1.6 years

First QC Date

August 21, 2023

Last Update Submit

January 21, 2026

Conditions

Keywords

naloxone trainingCommunity-engagement

Outcome Measures

Primary Outcomes (9)

  • Knowledge of overdose sign

    Investigators will use a subset of Opioid Overdose Knowledge Scale (OOKS) to measure through a forced choice scale with each choice coded as correct (=1) or incorrect (=0). Higher score indicated greater knowledge of overdose sign.

    up to 2 weeks

  • Knowledge of overdose management

    Investigators will use a subset of Opioid Overdose Knowledge Scale (OOKS) to measure through a forced choice scale with each choice coded as correct (=1) or incorrect (=0). Higher score indicated greater knowledge of overdose management.

    up to 2 weeks

  • Self-Efficacy toward intervening opioid overdose

    Investigators will modify self-efficacy scale developed and theorized by Bandura (2005). Response options are from 0 (no confident) to 100 (highly confident). Higher score indicates greater self-efficacy

    up to 2 weeks

  • Response efficacy about intervening opioid overdose

    Investigators will develop and measure how participants perceive the effectiveness of activities to intervene opioid overdose events in communities. Response options are from 0 (not effective) to 100 (highly effective). Higher score indicate greater response efficacy.

    up to 2 weeks

  • Concerns related to overdose management

    Investigators will use a subset of Opioid Overdose Attitude Scale (OOAS) with 5 point scale (1: strongly disagree \~5: strongly agree). Higher score indicates the greater concerns.

    up to 2 weeks

  • Intent to intervene opioid overdose events in communities

    Investigators will use behavioral intention scale developed by in the opioid training literature (Hecht et al., 2023) to measure intent to intervene opioid overdose events in communities (e.g., administering Narcan). Response options are from 1 (strongly disagree) to 5 (strongly agree). Higher scores indicates grater intention to intervene opioid overdose events in communities.

    up to 2 weeks

  • The number of days per week, on average, to carry Narcan

    Single item: how many days per week, on average, participants carry Narcn

    Up to 6 months

  • Number of Participants to response to overdose events from PulsePoint app.

    Single item: whether participant response to overdose events from PulsePoint notifications/alerts

    Up to 6 months

  • Number of participants to administer Narcan

    Single item: Whether participant administer Narcan to respond opioid overdose events in communities.

    Up to 6 months

Study Arms (2)

ORRS training group

EXPERIMENTAL

Online Naloxone training

Behavioral: Opioid Rapid Resonse System (ORRS) training

Waitlist group

SHAM COMPARATOR

Participants will receive non-active opioid overdose response training. Investigators will provide online training about opioid prevalence in US, opioid mechanism, side effect, and addiction. However, Investigators do not provide any knowledge about opioid overdose management and naloxone in this training. Once the project is completed, participants will receive online Naloxone training.

Behavioral: Non-active opioid overdose response training

Interventions

ORRS is on online system to train citizen responders to administer NARCAN to save the lives of opioid overdose victims. It capitalizes on the innovative PulsePoint technology to connect responders to overdose events. PulsePoint is an app that connects 911 requesting assistance for cardiac arrests to responders with Cardiopulmonary Resuscitation (CPR) training. ORRS allows us to partner with PulsePoint users to expand its reach to opioid overdoses, which share the need for a quick response that emergency responders are often unable to provide. ORRS has the advantage of expanding the population of responders with NARCAN, rescue breathing, and CPR training that can be connected to overdose events, increasing the likelihood of saving overdose victims' lives through a quick, efficient response. ORRS is delivered through an interactive, digital platform containing sequential, multi-media modules.

ORRS training group

Investigators will provide online training about opioid prevalence in US, opioid mechanism, side effect, and addiction. However, Investigators do not provide any knowledge about opioid overdose management and naloxone in this training. Once the project is completed, participants will receive online Naloxone training.

Waitlist group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Citizens who live in participating PulsePoint communities
  • Must to be 18 and older
  • Must be fluent in English
  • Must have access to the mobile data and able to download and use apps in a smartphone

You may not qualify if:

  • Citizens who do not live in participating PulsePoint communities
  • Under 18-year-old
  • Citizens who are not fluent in English
  • Citizens who do not have access to mobile data and unable to download and use apps in a smartphone.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ewald & Wasserman Research Consultants, LLC

San Francisco, California, 94104, United States

Location

Related Publications (1)

  • Carr DL, Hecht ML, Shiota MN, Zalake M, Krieger J, Choi HJ. Protocol for a national randomized controlled trial evaluating the Opioid Rapid Response System for overdose death prevention. Contemp Clin Trials. 2025 Mar;150:107835. doi: 10.1016/j.cct.2025.107835. Epub 2025 Feb 3.

MeSH Terms

Conditions

Opiate Overdose

Condition Hierarchy (Ancestors)

Drug OverdosePrescription Drug MisuseDrug MisuseSubstance-Related DisordersChemically-Induced DisordersOpioid-Related DisordersNarcotic-Related DisordersMental Disorders

Study Officials

  • Hye Jeong Choi

    Univeristy of Missouri

    PRINCIPAL INVESTIGATOR
  • Michael Hecht

    Real Prevention

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 21, 2023

First Posted

February 2, 2024

Study Start

May 24, 2024

Primary Completion

December 29, 2025

Study Completion

December 29, 2025

Last Updated

January 23, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Because this study is funded as a part of NIH HEAL initiative, investigators will follow the HEAL data sharing policy.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
When project is completed.

Locations